HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 177 filers reported holding HERON THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.05 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,375,628 | -11.2% | 8,131,678 | 0.0% | 0.05% | -12.7% |
| Q2 2023 | $9,432,746 | -23.2% | 8,131,678 | 0.0% | 0.06% | -17.9% |
| Q1 2023 | $12,278,834 | -39.6% | 8,131,678 | 0.0% | 0.07% | -45.1% |
| Q4 2022 | $20,329,195 | -40.8% | 8,131,678 | 0.0% | 0.12% | -45.8% |
| Q3 2022 | $34,316,000 | +51.3% | 8,131,678 | 0.0% | 0.22% | +74.4% |
| Q2 2022 | $22,687,000 | -51.2% | 8,131,678 | 0.0% | 0.13% | -51.7% |
| Q1 2022 | $46,513,000 | -37.3% | 8,131,678 | 0.0% | 0.27% | -26.0% |
| Q4 2021 | $74,242,000 | -14.6% | 8,131,678 | 0.0% | 0.36% | -5.5% |
| Q3 2021 | $86,928,000 | -31.1% | 8,131,678 | 0.0% | 0.38% | -31.0% |
| Q2 2021 | $126,204,000 | +29.9% | 8,131,678 | +35.6% | 0.55% | +31.6% |
| Q1 2021 | $97,174,000 | -23.4% | 5,994,704 | 0.0% | 0.42% | -11.9% |
| Q4 2020 | $126,878,000 | +42.8% | 5,994,704 | 0.0% | 0.48% | +34.6% |
| Q3 2020 | $88,842,000 | +0.4% | 5,994,704 | -0.4% | 0.36% | -9.0% |
| Q2 2020 | $88,526,000 | +25.3% | 6,018,104 | 0.0% | 0.39% | -10.3% |
| Q1 2020 | $70,653,000 | -50.0% | 6,018,104 | 0.0% | 0.44% | -42.2% |
| Q4 2019 | $141,425,000 | +27.0% | 6,018,104 | 0.0% | 0.75% | -0.7% |
| Q3 2019 | $111,335,000 | -0.5% | 6,018,104 | 0.0% | 0.76% | -0.4% |
| Q2 2019 | $111,877,000 | -8.8% | 6,018,104 | +19.9% | 0.76% | -3.2% |
| Q1 2019 | $122,642,000 | -5.8% | 5,018,104 | 0.0% | 0.78% | -26.4% |
| Q4 2018 | $130,170,000 | -18.2% | 5,018,104 | -0.1% | 1.07% | +1.7% |
| Q3 2018 | $159,051,000 | -18.5% | 5,025,298 | 0.0% | 1.05% | -28.6% |
| Q2 2018 | $195,233,000 | +40.8% | 5,025,298 | 0.0% | 1.47% | +24.7% |
| Q1 2018 | $138,698,000 | +150.4% | 5,025,298 | +64.2% | 1.18% | +145.0% |
| Q4 2017 | $55,398,000 | +23.0% | 3,060,641 | +9.8% | 0.48% | +31.5% |
| Q3 2017 | $45,026,000 | +16.8% | 2,787,992 | +0.2% | 0.36% | +8.3% |
| Q2 2017 | $38,552,000 | -7.7% | 2,783,569 | 0.0% | 0.34% | -1.5% |
| Q1 2017 | $41,754,000 | +33.7% | 2,783,569 | +16.8% | 0.34% | +11.8% |
| Q4 2016 | $31,225,000 | -36.6% | 2,383,569 | -16.6% | 0.31% | -31.5% |
| Q3 2016 | $49,230,000 | -4.5% | 2,857,250 | 0.0% | 0.45% | -17.4% |
| Q2 2016 | $51,573,000 | -6.6% | 2,857,250 | -1.7% | 0.54% | -7.0% |
| Q1 2016 | $55,219,000 | -28.9% | 2,907,784 | 0.0% | 0.58% | -9.5% |
| Q4 2015 | $77,638,000 | +9.4% | 2,907,784 | 0.0% | 0.64% | -2.0% |
| Q3 2015 | $70,950,000 | -18.9% | 2,907,784 | +3.6% | 0.66% | -14.5% |
| Q2 2015 | $87,491,000 | +130.6% | 2,807,784 | +7.7% | 0.77% | +142.7% |
| Q1 2015 | $37,943,000 | +44.6% | 2,607,784 | 0.0% | 0.32% | +17.9% |
| Q4 2014 | $26,234,000 | +20.8% | 2,607,784 | 0.0% | 0.27% | -2.2% |
| Q3 2014 | $21,723,000 | -32.4% | 2,607,784 | 0.0% | 0.27% | -30.5% |
| Q2 2014 | $32,128,000 | +6.5% | 2,607,784 | +20.3% | 0.39% | +2.9% |
| Q1 2014 | $30,153,000 | – | 2,167,784 | – | 0.38% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG KEVIN C | 21,288 | $250,000 | 19.87% |
| TANG CAPITAL MANAGEMENT LLC | 2,896,904 | $34,010,000 | 4.78% |
| PFM Health Sciences, LP | 2,481,917 | $29,138,000 | 2.39% |
| Iron Triangle Partners LP | 500,000 | $5,870,000 | 2.27% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 777,599 | $9,129,000 | 1.72% |
| Pekin Hardy Strauss, Inc. | 588,732 | $6,912,000 | 1.55% |
| First Light Asset Management, LLC | 691,400 | $8,117,000 | 1.39% |
| Congress Park Capital LLC | 111,045 | $1,304,000 | 1.18% |
| Mesirow Financial Investment Management, Inc. | 15,135 | $178,000 | 1.12% |
| Elk Creek Partners, LLC | 509,174 | $5,978,000 | 1.03% |